Ignet

Gene Information

Gene symbol: KLRK1

Gene name: killer cell lectin-like receptor subfamily K, member 1

HGNC ID: 18788

Synonyms: NKG2D, KLR, NKG2-D, CD314

Related Genes

#	Gene Symbol	Number of hits
1	CD8A	1 hits
2	IFNG	1 hits
3	MICA	1 hits

Related Sentences

#	PMID	Sentence
1	15490153	MHC class I chain-related gene A (MICA), a putative independent susceptibility gene in autoimmune diseases, encodes a surface protein present in epithelial cells that binds to NKG2D, an activating receptor of NK, alphabeta and gammadelta T cells, and could function as a stress-inducible activator of the innate immune response.
2	15490153	Total RNA was purified and MICA, IFNG and NKG2D mRNA were quantified by fluorescent real-time RT-PCR.
3	15490153	MICA expression was detected in both patients and controls, but incubation with gliadin induced a strong increase in samples from the treated CD group compared with the non-CD controls (P=0.028), while no differences were observed for IFNG or NKG2D mRNA levels.
4	15490153	MHC class I chain-related gene A (MICA), a putative independent susceptibility gene in autoimmune diseases, encodes a surface protein present in epithelial cells that binds to NKG2D, an activating receptor of NK, alphabeta and gammadelta T cells, and could function as a stress-inducible activator of the innate immune response.
5	15490153	Total RNA was purified and MICA, IFNG and NKG2D mRNA were quantified by fluorescent real-time RT-PCR.
6	15490153	MICA expression was detected in both patients and controls, but incubation with gliadin induced a strong increase in samples from the treated CD group compared with the non-CD controls (P=0.028), while no differences were observed for IFNG or NKG2D mRNA levels.
7	15490153	MHC class I chain-related gene A (MICA), a putative independent susceptibility gene in autoimmune diseases, encodes a surface protein present in epithelial cells that binds to NKG2D, an activating receptor of NK, alphabeta and gammadelta T cells, and could function as a stress-inducible activator of the innate immune response.
8	15490153	Total RNA was purified and MICA, IFNG and NKG2D mRNA were quantified by fluorescent real-time RT-PCR.
9	15490153	MICA expression was detected in both patients and controls, but incubation with gliadin induced a strong increase in samples from the treated CD group compared with the non-CD controls (P=0.028), while no differences were observed for IFNG or NKG2D mRNA levels.
10	20484740	Murine trophoblast cells induce NK cell interferon-gamma production through KLRK1.
11	20484740	We suggest that the interaction of KLRK1 and RAET1 may be involved in IFNG production by uNK cells, and thus, this receptor-ligand pair may contribute to successful murine implantation site development.
12	20484740	Murine trophoblast cells induce NK cell interferon-gamma production through KLRK1.
13	20484740	We suggest that the interaction of KLRK1 and RAET1 may be involved in IFNG production by uNK cells, and thus, this receptor-ligand pair may contribute to successful murine implantation site development.
14	21893449	Premalignant quiescent melanocytic nevi do not express the MHC class I chain-related protein A.
15	21893449	The MHC class I chain-related protein A (MICA) is an inducible molecule almost not expressed by normal cells but strongly up-regulated in tumor cells.
16	21893449	MICA-expressing cells are recognized by natural killer (NK) cells, CD8+ abTCR and gdTCR T lymphocytes through the NKG2D receptor.
17	21893449	Engagement of NKG2D by MICA triggers IFN-g secretion and cytotoxicity against malignant cells.
18	21893449	Premalignant quiescent melanocytic nevi do not express the MHC class I chain-related protein A.
19	21893449	The MHC class I chain-related protein A (MICA) is an inducible molecule almost not expressed by normal cells but strongly up-regulated in tumor cells.
20	21893449	MICA-expressing cells are recognized by natural killer (NK) cells, CD8+ abTCR and gdTCR T lymphocytes through the NKG2D receptor.
21	21893449	Engagement of NKG2D by MICA triggers IFN-g secretion and cytotoxicity against malignant cells.